Cite
Identification of Hub Genes and Small Molecule Drugs Associated with Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer
MLA
Guangda Li, et al. “Identification of Hub Genes and Small Molecule Drugs Associated with Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer.” Journal of Cancer, vol. 12, Jan. 2021, pp. 5286–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....11bdf541862238683c144fede59f5ee3&authtype=sso&custid=ns315887.
APA
Guangda Li, Xiaoxiao Li, Yunfei Ma, Mingwei Yu, Xinjie Chen, Xiaomin Wang, Yu Gao, Pei-Yu Cheng, & Gan-Lin Zhang. (2021). Identification of Hub Genes and Small Molecule Drugs Associated with Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer. Journal of Cancer, 12, 5286–5295.
Chicago
Guangda Li, Xiaoxiao Li, Yunfei Ma, Mingwei Yu, Xinjie Chen, Xiaomin Wang, Yu Gao, Pei-Yu Cheng, and Gan-Lin Zhang. 2021. “Identification of Hub Genes and Small Molecule Drugs Associated with Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer.” Journal of Cancer 12 (January): 5286–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....11bdf541862238683c144fede59f5ee3&authtype=sso&custid=ns315887.